首页> 外文期刊>National Journal of Community Medicine >Coverage Evaluation and Compliance of Mass Drug Administration Campaign in Nanded District of Maharashtra
【24h】

Coverage Evaluation and Compliance of Mass Drug Administration Campaign in Nanded District of Maharashtra

机译:马哈拉施特拉邦南德区大规模药物管理运动的覆盖率评估和合规性

获取原文
       

摘要

"Background: Lymphatic filariasis (LF) is endemic in 83 countries and territories. In view with the global elimination, mass drug administration (MDA) with single dose of diethyl carbamazine and albendazole tablets was carried out for the eligible population in Nanded district. The study was conducted to assess coverage, compliance and reasons for noncompliance to MDA in Nanded district. Method: A community-based cross-sectional study was done by house-to-house visit in Nanded district. Three rural and one urban clusters of Nanded district, Maharashtra, were selected. A predesigned questionnaire was used to collect information. Drug coverage, compliance, effective coverage, coverage–compliance gap (CCG), reasons for noncompliance were studied. Statistical analysis was done by SPSS version 16. Results: The total numbers of houses surveyed were 120. Cover-age rate was 94.40%, and compliance rate, CCG, effective coverage rate was 51.81%, 8.48%, and 48.91%, respectively. The compliance of drugs by eligible population was slightly higher in urban area (95.41%) than the rural area (90.56%). Major reasons for non consumption of drug were empty stomach during Drug distributor (DD) visit. Conclusion: The drug compliance need to be improved. Issues like fear of side effects should be addressed through effective behavior change communication strategies.
机译:“背景:淋巴丝虫病(LF)在83个国家和地区是地方性流行。鉴于全球范围内的消灭,在南德地区的合格人群中进行了单剂量二乙基卡巴嗪和阿苯达唑片剂的大规模药物管理(MDA)。方法:在楠德区进行逐户访问,以社区为基础的横断面研究;楠德区的三个农村和一个城市集群选择马哈拉施特拉邦(Maharashtra),使用预先设计的调查表收集信息,研究药物覆盖率,依从性,有效覆盖率,覆盖率-达标差距(CCG),不达标的原因,并按SPSS第16版进行统计分析。被调查的房屋数量为120个,覆盖率达94.40%,履约率,CCG,有效覆盖率分别为51.81%,8.48%和48.91%。符合条件的人群中,城市地区的毒品(95.41%)略高于农村地区(90.56%)。不消费药物的主要原因是在药物分销商(DD)访问期间肚子空了。结论:药物依从性有待提高。应该通过有效的行为改变沟通策略来解决诸如担心副作用之类的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号